Definitive Contract HHSN268201300063C

<p>This is a $3,399,279.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Pediastent LLC, a minority-owned, woman-owned limited liability company, for the development leading to the commercialization of a bioresorbable stent for the treatment of coarctation of the aorta in neonates. The contract is a definitive, firm-fixed-price contract with a period of performance ending on March 22, 2022.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lyra Therapeutics Inc. for the development of a bioresorbable stent to treat coarctation of the aorta in neonates. The contract has a firm fixed price of $1,064,068.64 and is set to be completed by November 30, 2020. This SBIR contract is focused on the early-stage development and commercialization of the bioresorbable stent technology.

This is a federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Transmural Systems LLC, a woman-owned small business. The $2,999,984 Firm Fixed Price contract is for the development of a Transcatheter Cavopulmonary Bypass Endograft, which is a medical device to treat congenital heart disease. This contract was awarded as a Direct to Phase II Small Business Innovation Research (SBIR) project, indicating it builds upon prior SBIR-funded research...

This is a $199,999 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Aravasc, Inc., a minority-owned, woman-owned small business located in Sunnyvale, California. The contract is for the development of a multifunctional drug-delivery stent with a nanoporous coating. The contract is a firm-fixed price definitive contract with a completion date of June 23, 2011. This SBIR Phase I award is part of the NCI's...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, to develop a Transcatheter Cavopulmonary Bypass Endograft (TCBE) device for treating congenital heart disease. The potential value of the contract is $440,000.00. Transmural Systems has previously worked on various catheter-based cardiovascular devices under past federal...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a &quot;Multiplex Label-Free Nanowell Technology...

This contract award was made by the National Heart Lung and Blood Institute, a civilian agency, to Physical Optics Corporation, a small business, for a Phase I Small Business Innovation Research (SBIR) project focused on developing a cardiotoxicity biomarker sensing device. The contract has a firm fixed price of $236,370.00 and a period of performance from August 10, 2016 to August 9, 2017. Physical Optics Corporation is a small business that specializes in delivering advanced technology...

This federal contract award, valued at $498,901.29, was granted to X-Biomedical Inc., a self-certified small disadvantaged, woman-owned, for-profit manufacturer of goods. The contract is part of the U.S. Department of Transportation's Small Business Innovation Research (SBIR) Program and is for the development of a &quot;Child Presence Detection CO2 Release Test Device&quot; under Topic 23-NH1. This Phase II contract follows a previous Phase I award of $146,929.62 and is a fixed-price,...

This federal contract award with ID HHSN268200700021C was made by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Biosurfaces Inc., a for-profit small business. The $100,000 firm fixed-price contract is for the development of critical technologies for ventricular assist devices under the SBIR Phase I program. The contract has a period of performance from September 30, 2007 to June 17, 2009. Biosurfaces Inc. specializes in...

This is a $149,998.00 Firm Fixed Price Definitive Contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the Department of Health and Human Services, to Pinmed, Inc., a small business manufacturer. The contract is for Phase I of the Small Business Innovation Research (SBIR) program, with the topic being &quot;In-Bore Defibrillation for Invasive Cardiology Procedures.&quot; The work will be performed in Pittsburgh, Pennsylvania and is set aside for small businesses....